Literature DB >> 17186258

Preclinical investigation of fluorometholone acetate as a potential new adjuvant during vitreous surgery.

Yasuaki Hata1, Hiroshi Enaida, Yukio Sassa, Akifumi Ueno, Muneki Miura, Toshio Hisatomi, Yoshinobu Goto, Tatsuro Ishibashi.   

Abstract

OBJECTIVE: To examine the effects of intravitreal fluorometholone acetate (FMT) on the morphology and function of the retina and to investigate its possible use for vitreous surgery.
METHODS: Brown Norway rat eyes (n = 6, 12 groups) were injected with 0.05 ml of SF6 gas for vitrectomization. Four weeks later, FMT solution was injected into the vitreous cavity/subretinal space of the vitrectomized eyes at doses of 10, 20, and 40 mg/ml (0.05 ml/eye, n = 12 for each group). The retinal function was evaluated by electroretinography (ERG) at 4 and 8 weeks after FMT injection. Retinal toxicity was also assessed histologically by a light microscopy. Sham-operated eyes (0.05 ml of irrigating solution, n = 12) were used as control animals. FMT-assisted pars plana vitrectomy with internal limiting membrane (ILM) peeling was performed in primate eyes (n = 2). Retinal toxicity was assessed by ophthalmoscope, fluorescein angiography and electron microscopy three months after the vitreous surgery.
RESULTS: There was no remarkable reduction in any ERG waves at either time interval at 4 and 8 weeks after the intravitreal/subretinal injection of FMT. No obvious histological change was observed in any of the rat eyes either. Using ophthalmoscope, fluorescein angiography and electron microscopy, the appearance of the primate retinas remained to be in a non-pathological condition.
CONCLUSION: FMT appears to be a potentially useful tool in assisting vitreous surgery including safe ILM peeling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17186258     DOI: 10.1007/s00417-006-0499-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  25 in total

1.  Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy.

Authors:  G A Peyman; R Cheema; M D Conway; T Fang
Journal:  Retina       Date:  2000       Impact factor: 4.256

Review 2.  Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

Authors:  Jost B Jonas
Journal:  Acta Ophthalmol Scand       Date:  2005-12

3.  Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes.

Authors:  M Veckeneer; K van Overdam; J Monzer; K Kobuch; W van Marle; H Spekreijse; J van Meurs
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-09       Impact factor: 3.117

4.  Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor.

Authors:  Y Hata; A Clermont; T Yamauchi; E A Pierce; I Suzuma; H Kagokawa; H Yoshikawa; G S Robinson; T Ishibashi; T Hashimoto; F Umeda; S E Bursell; L P Aiello
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

5.  Posterior subtenon triamcinolone acetonide for refractory diabetic macular edema.

Authors:  Sophie J Bakri; Peter K Kaiser
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

6.  Intravitreal triamcinolone injection for chronic diffuse diabetic macular oedema.

Authors:  Remzi Avci; Berkant Kaderli; Fatma D Akalp
Journal:  Clin Exp Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 4.207

7.  Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown.

Authors:  Taiji Sakamoto; Miho Miyazaki; Toshio Hisatomi; Takao Nakamura; Akifumi Ueno; Keiko Itaya; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-03-15       Impact factor: 3.117

8.  Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.

Authors:  K-H Sonoda; H Enaida; A Ueno; T Nakamura; Y-I Kawano; T Kubota; T Sakamoto; T Ishibashi
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

9.  Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases.

Authors:  Hiroshi Enaida; Yasuaki Hata; Akifumi Ueno; Takao Nakamura; Toshio Hisatomi; Miho Miyazaki; Kimihiko Fujisawa; Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Retina       Date:  2003-12       Impact factor: 4.256

10.  [Retinal toxicity of intravitreally injected steroids on the rabbit eye].

Authors:  M Kamei; Y Tano; H Sakai; F Nakazawa; E Shirasawa; Y Ishii
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-10
View more
  1 in total

1.  GFAP-driven GFP expression in activated mouse Müller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectors.

Authors:  Wendy M Aartsen; Koen W R van Cleef; Lucie P Pellissier; Robert M Hoek; Rogier M Vos; Bas Blits; Erich M E Ehlert; Kamaljit S Balaggan; Robin R Ali; Joost Verhaagen; Jan Wijnholds
Journal:  PLoS One       Date:  2010-08-24       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.